Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Diabetic Peripheral Neuropathy Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

3 recruiting trials for Diabetic Peripheral Neuropathy. Eligibility criteria explained in plain English.

TrialFinderData lists 3 Diabetic Peripheral Neuropathy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Every phased trial in this set is Early Phase 1 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.

Research is led by Florida Institute for Human and Machine Cognition (1), Chongqing Medical University (1), Carilion Clinic (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Clinical Evaluation (other, 1 trial), followed by Plantar Pressure Biofeedback Gait Training, Propulsion Biofeedback Gait Training.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Track Diabetic Peripheral Neuropathy trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06591780

Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy

This study aims to collect data to improve gait function in individuals with Diabetic Peripheral Neuropathy (DPN). The primary goals are to evaluate: * Biomechanical mechanisms...

Sponsor: Florida Institute for Human and Machine CognitionEnrolling: 251 location
RECRUITINGNCT07625007

Shortwave Intervention for Diabetic Peripheral Neuropathy.

This study is a single-center, randomized, single-blind, sham-controlled clinical trial aimed at evaluating the efficacy and safety of shortwave therapy administered for five...

Sponsor: Chongqing Medical UniversityEnrolling: 2021 location
RECRUITINGEarly Phase 1NCT07260656

Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain

The purpose of this research is to assess whether the use of a topical cream with an active ingredient can reduce the amount of foot pain experienced in participants who have been...

Sponsor: Carilion ClinicEnrolling: 801 location

Frequently Asked Questions

There are currently 3 clinical trials for Diabetic Peripheral Neuropathy, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Diabetic Peripheral Neuropathy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Diabetic Peripheral Neuropathy, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.